Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

165,968 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Case Report: A good response to furmonertinib second-line treatment of an advanced lung adenocarcinoma patient with a rare EGFR exon 20 N771_P772insH mutation: A case report and literature review.
Zhang X, Han H, Zhao J, Liu X, Zhang J, Sun R, Li S, Liu B, Zhu H, Jiao S, Li X, Tang H. Zhang X, et al. Among authors: zhang j. Front Pharmacol. 2022 Aug 17;13:964606. doi: 10.3389/fphar.2022.964606. eCollection 2022. Front Pharmacol. 2022. PMID: 36059942 Free PMC article.
First report of furmonertinib as a first-line treatment in advanced lung adenocarcinoma patients harboring EGFR exon 20 insertion mutations after the kinase domain αC-helix: Two case reports and a literature review.
Han H, Zhang X, Liu X, Zhao J, Zhang J, Zhang J, Zhu H, Jiao S, Tang H. Han H, et al. Among authors: zhang j, zhang x. Medicine (Baltimore). 2023 Dec 29;102(52):e36667. doi: 10.1097/MD.0000000000036667. Medicine (Baltimore). 2023. PMID: 38206746 Free PMC article. Review.
165,968 results
You have reached the last available page of results. Please see the User Guide for more information.